In the intricate world of pharmaceutical manufacturing, the quality and reliability of intermediate compounds are paramount. Among these, 4-(4-Aminophenyl)morpholin-3-one, identified by CAS number 438056-69-0, stands out as a critical building block, particularly in the synthesis of Rivaroxaban. As a leading manufacturer and supplier of this vital pharmaceutical intermediate, we understand the precise requirements of global R&D scientists and procurement managers.

Rivaroxaban, a widely prescribed anticoagulant, relies on a well-defined synthetic pathway. 4-(4-Aminophenyl)morpholin-3-one serves as a key starting material (KSM) or an advanced intermediate in this process. Its chemical structure, featuring an aniline and a morpholinone moiety, provides the necessary framework for subsequent reactions that lead to the final active pharmaceutical ingredient (API). For pharmaceutical companies looking to buy this compound, ensuring its purity, consistency, and secure supply is non-negotiable. A high assay, typically ≥99.0%, is essential to prevent unwanted side reactions and to guarantee the efficacy and safety of the final drug product.

When sourcing 4-(4-Aminophenyl)morpholin-3-one, procurement managers often search for terms like 'Rivaroxaban intermediate manufacturer China' or 'high purity 438056-69-0 supplier'. This reflects the global demand for reliable sources that can offer competitive pricing without compromising on quality. The physical properties of this compound, such as its appearance as a white to light yellow solid, along with low moisture content (≤1.0%), are important indicators of its quality and suitability for pharmaceutical use. These characteristics are meticulously controlled in our manufacturing facilities.

Our role as a dedicated supplier extends beyond simply providing the chemical. We ensure that our clients receive the exact specifications they need, with options for custom packaging like 25 kg drums to facilitate large-scale production. By partnering with a reputable Chinese manufacturer, pharmaceutical companies can mitigate risks associated with supply chain disruptions and ensure a steady flow of this indispensable intermediate. If you are in the process of drug development and require a dependable source for 4-(4-Aminophenyl)morpholin-3-one, reaching out for a quote is the first step towards securing your production needs.